Patterns of forearm lymphatic drainage to the epitrochlear lymph nodes in 1400 cutaneous melanoma patients.

breast cancer‐related lymphedema epitrochlear lymph node lymphatic drainage melanoma

Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 25 07 2024
accepted: 02 08 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

Variations of hand and forearm lymphatic drainage to upper-arm lymphatic pathways may impact the route of melanoma metastasis. This study compared rates of lymphatic drainage to epitrochlear nodes between anatomic divisions of the hand and forearm to determine whether the anatomic distribution of hand and forearm melanomas affects the likelihood of drainage to epitrochlear lymph nodes. Using a single-institution lymphoscintigraphy database, we identified all patients with cutaneous melanoma on the hand and forearm. A body-map two-dimensional coordinate system was used to classify cutaneous melanoma sites between radial-ulnar and dorsal-volar divisions. Sentinel lymph nodes (SLNs) visualized on lymphoscintigraphy were recorded. Proportions of patients with epitrochlear SLNs were compared between anatomic divisions using χ Of 3628 upper extremity cutaneous melanoma patients who underwent lymphatic mapping with lymphoscintigraphy, 1400 met inclusion criteria. Twenty-one percent of patients demonstrated epitrochlear SLNs. Epitrochlear SLNs were observed in 27% of dorsal forearm melanomas and 15% of volar forearm melanomas (p < 0.001). Epitrochlear SLNs were observed in 31% of ulnar forearm melanomas and 17% of radial forearm melanomas (p < 0.001). Higher proportions of dorsal and ulnar forearm melanomas have epitrochlear SLNs. Metastasis to epitrochlear SLNs may be more likely from melanomas in these respective forearm regions.

Sections du résumé

BACKGROUND BACKGROUND
Variations of hand and forearm lymphatic drainage to upper-arm lymphatic pathways may impact the route of melanoma metastasis. This study compared rates of lymphatic drainage to epitrochlear nodes between anatomic divisions of the hand and forearm to determine whether the anatomic distribution of hand and forearm melanomas affects the likelihood of drainage to epitrochlear lymph nodes.
METHODS METHODS
Using a single-institution lymphoscintigraphy database, we identified all patients with cutaneous melanoma on the hand and forearm. A body-map two-dimensional coordinate system was used to classify cutaneous melanoma sites between radial-ulnar and dorsal-volar divisions. Sentinel lymph nodes (SLNs) visualized on lymphoscintigraphy were recorded. Proportions of patients with epitrochlear SLNs were compared between anatomic divisions using χ
RESULTS RESULTS
Of 3628 upper extremity cutaneous melanoma patients who underwent lymphatic mapping with lymphoscintigraphy, 1400 met inclusion criteria. Twenty-one percent of patients demonstrated epitrochlear SLNs. Epitrochlear SLNs were observed in 27% of dorsal forearm melanomas and 15% of volar forearm melanomas (p < 0.001). Epitrochlear SLNs were observed in 31% of ulnar forearm melanomas and 17% of radial forearm melanomas (p < 0.001).
CONCLUSIONS CONCLUSIONS
Higher proportions of dorsal and ulnar forearm melanomas have epitrochlear SLNs. Metastasis to epitrochlear SLNs may be more likely from melanomas in these respective forearm regions.

Identifiants

pubmed: 39138920
doi: 10.1002/jso.27811
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : JOBST Foundation
ID : 2023 JOBST Lymphatic Research Grant
Organisme : NHLBI NIH HHS
ID : R01HL157991
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54HL165440
Pays : United States
Organisme : Health Research Council of New Zealand
ID : Sir Charles Health Research Fellowship
Organisme : New Zealand Ministry of Business, Innovation and Employment
ID : 12 Labours project grant
Organisme : University of Auckland
ID : Strategic Research Investment Fund Grant

Informations de copyright

© 2024 The Author(s). Journal of Surgical Oncology published by Wiley Periodicals LLC.

Références

Tomizuka T, Namikawa K, Higashi T. Characteristics of melanoma in Japan: a nationwide registry analysis 2011‐2013. Melanoma Res. 2017;27(5):492‐497. doi:10.1097/CMR.0000000000000375
Elwood JM, Gallagher RP. Site distribution of malignant melanoma. Can Med Assoc J. 1983;128:1400‐1404.
Pearl DK, Scott EL. The anatomical distribution of skin cancers. Int J Epidemiol. 1986;15:502‐506.
Bulliard JL, De Weck D, Fisch T, Bordoni A, Levi F. Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann Oncol. 2007;18(4):789‐794. doi:10.1093/annonc/mdl490
Bulliard J‐L, Cox B, Elwood JM. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer. 1997;72:231‐235.
van der Spek‐Keijser LMT, van der Rhee HJ, Tóth G, Van Westering R, Bruijn JA, Coebergh JWW. Site, histological type, and thickness of primary cutaneous malignant melanoma in Western Netherlands since 1980. Br J Dermatol. 1997;136:565‐571.
Bulliard J‐L, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969–1993. Int J Epidemiol. 2000;29:416‐423.
Bulliard J‐L, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969–93. Cancer Causes Control. 1999;10:407‐416.
Chen YT, Zheng T, Holford TR, Berwick M, Dubrow R. Malignant melanoma incidence in Connecticut (United States): time trends and age‐period‐cohort modeling by anatomic site. Cancer Causes Control. 1994;5:341‐350.
MacKie RM, Bray CA, Hole DJ, et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002;360(9333):587‐591. doi:10.1016/S0140-6736(02)09779-9
Önefäldt D, Zommorodi S, Falk Delgado A. Location of cutaneous malignant melanoma in Sweden 2004‐2018—mortality and sex differences. J Plast Reconstr Aesthet Surg. 2022;75(9):3398‐3405. doi:10.1016/j.bjps.2022.04.093
Wee E, Wolfe R, Mclean C, Kelly JW, Pan Y. The anatomic distribution of cutaneous melanoma: a detailed study of 5141 lesions. Australas J Dermatol. 2020;61(2):125‐133. doi:10.1111/ajd.13223
Alicea GM, Rebecca VW. Un‐fair skin: racial disparities in acral melanoma research. Nat Rev Cancer. 2022;22(3):127‐128. doi:10.1038/s41568-022-00443-8
Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986‐2005. Arch Dermatol. 2009;145(4):427‐434. doi:10.1001/archdermatol.2008.609
Tas F, Erturk K. Limb melanomas: acral melanomas have worse survival. J Dermatolog Treat. 2022;33(3):1630‐1637. doi:10.1080/09546634.2021.1877248
Carter TM, Strassle PD, Ollila DW, Stitzenberg KB, Meyers MO, Maduekwe UN. Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients? Am J Surg. 2021;221(4):706‐711. doi:10.1016/j.amjsurg.2020.12.040
Mulenga M, Montgomery ND, Chagomerana M, et al. Epidemiological and histopathological profile of malignant melanoma in Malawi. BMC Clin Pathol. 2019;19:5. doi:10.1186/s12907-019-0087-6
Zemelman V, Roa J, Tagle SR, Valenzuela CY. Malignant melanoma in Chile: an unusual distribution of primary sites in men from low socioeconomic strata. Clin Exp Dermatol. 2006;31(3):335‐338. doi:10.1111/j.1365-2230.2005.02038.x
Zemelman VB, Valenzuela CY, Sazunic I, Araya I. Malignant melanoma in Chile: different site distribution between private and state patients. Biol Res. 2014;47(1):34. doi:10.1186/0717-6287-47-34
Granoff MD, Pardo JA, Johnson AR, et al. Superficial and functional lymphatic anatomy of the upper extremity. Plast Reconst Surg. 2022;150(4):900‐907. doi:10.1097/PRS.0000000000009555
Friedman R, Bustos VP, Pardo J, et al. Superficial and functional imaging of the tricipital lymphatic pathway: a modern reintroduction. Breast Cancer Res Treat. 2023;197(1):235‐242. doi:10.1007/s10549-022-06777-z
Aydin MA, Okudan B, Nasir S, Özbek M, Karagöz A, Altuntaş S. Lymphoscintigraphic drainage of acral limb skin to interval sentinel lymph nodes in healthy subjects. J Surg Oncol. 2006;93(4):286‐293. doi:10.1002/jso.20385
Suami H, Pan WR, Taylor GI. Changes in the lymph structure of the upper limb after axillary dissection: radiographic and anatomical study in a human cadaver. Plast Reconstr Surg. 2007;120(4):982‐991. doi:10.1097/01.prs.0000277995.25009.3e
Hunt JA, Thompson JF, Uren RF, Howman‐Giles R, Harman CR. Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol. 1998;5(3):248‐252. doi:10.1007/BF02303781
Uren RF, Howman‐Giles RB, Thompson JF. Failure to detect drainage to the popliteal and epitrochlear lymph nodes on cutaneous lymphoscintigraphy in melanoma patients. J Nucl Med. 1998;39(12):2195.
Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg. 1999;189(2):195‐204. doi:10.1016/s1072-7515(99)00108-8
McMasters KM. Interval sentinel lymph nodes in melanoma. AArch Surg. 2002;137(5):543‐549. doi:10.1001/archsurg.137.5.543
Sumner WE, Ross MI, Mansfield PF, et al. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer. 2002;95(2):354‐360. doi:10.1002/cncr.10664
Uren RF, Howman‐Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003;44(4):570‐582.
Ishihara T, Kageshita T, Matsushita S, Ono T. Investigation of sentinel lymph nodes of the axillary and cubital regions in upper‐extremity malignant skin tumors: a series of 15 patients. Int J Clin Oncol. 2003;8(5):297‐300. doi:10.1007/s10147-003-0336-6
Ishihara T, Kaguchi A, Matsushita S, et al. Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single‐photon‐emission computed tomography/computed tomography combined system. Int J Clin Oncol. 2006;11(3):214‐220. doi:10.1007/s10147-005-0554-1
Kidner TB, Yoon JL, Faries MB, Morton DL. Epitrochlear sentinel lymph nodes in melanoma: interval or independent? Am Surg. 2012;78(6):702‐705.
Hayashi T, Furukawa H, Oyama A, Funayama E, Saito A, Yamamoto Y. Dominant lymph drainage in the upper extremity and upper trunk region: evaluation of lymph drainage in patients with skin melanomas. Int J Clin Oncol. 2014;19(1):193‐197. doi:10.1007/s10147-012-0504-7
Jinnai S, Namikawa K, Takahashi A, Ogata D, Yamazaki N. Incidence and patterns of lymphatic drainage to the epitrochlear and popliteal sentinel lymph nodes in malignant melanoma of the distal extremities: a single‐institution retrospective study. Int J Dermatol. 2022;61(7):855‐860. doi:10.1111/ijd.16078
Covarelli P, Tomassini GM, Servoli A, Picciotto F, Noya G. Epitrochlear lymph node dissection and axillary lymph node biopsy. an unusual clinical presentation in a patient with forearm melanoma. Ann Surg Oncol. 2013;20(13):4378. doi:10.1245/s10434-013-3185-1
Yoshida Y, Takahashi A, Koga M, Koga K, Kubota Y, Nakayama J. Case of metastatic melanoma in an epitrochlear lymph node arising in a pregnant woman. J Dermatol. 2007;34(1):48‐51. doi:10.1111/j.1346-8138.2007.00215.x
Cozzaglio L, Marazzi F, Quagliuolo V. Epitrochlear lymph node basin in melanoma: an extension of the axillary station or an independent basin? Updates Surg. 2018;70(4):573‐574. doi:10.1007/s13304-018-0521-9
Ozkan E, Eroglu A. The utility of intraoperative handheld gamma camera for detection of sentinel lymph nodes in melanoma. Nucl Med Mol Imaging. 2015;49(4):318‐320. doi:10.1007/s13139-015-0341-5
West NJ, Wadhwa S, Ayars C, et al. Interval sentinel lymph nodes with the use of routine lymphoscintigraphy in extremity melanoma. J Surg Res. 2024;293:613‐617. doi:10.1016/j.jss.2023.08.055
Smith TJ, Sloan GM, Baker AR. Epitrochlear node involvement in melanoma of the upper extremity. Cancer. 1983;51(4):756‐760. doi:10.1002/1097-0142(19830215)51:4<756::aid-cncr2820510435>3.0.co;2-t
Reynolds HM, Dunbar PR, Uren RF, Thompson JF, Smith NP. Mapping melanoma lymphoscintigraphy data onto a 3D anatomically based model. Ann Biomed Eng. 2007;35(8):1444‐1457. doi:10.1007/s10439-007-9315-9
Ackerman MJ. The visible human project. Proc IEEE. 1998;86:504‐511.
Reynolds HM, Dunbar PR, Uren RF, Blackett SA, Thompson JF, Smith NP. Three‐dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma. Lancet Oncol. 2007;8(9):806‐812. doi:10.1016/S1470-2045(07)70176-6
Reynolds HM, Smith NP, Uren RF, Thompson JF, Dunbar PR. Three‐dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head Neck. 2009;31(10):1316‐1325. doi:10.1002/hed.21089
Williams PL, Warwick W, Dyson M, et al. Gray's Anatomy. 37th ed. Churchill Livingstone; 1989.
Abdelfattah U, Jaimez PM, Clavero JA, Bellantonio V, Pons G, Masia J. Correlation between superficial and deep lymphatic systems using magnetic resonance lymphangiography in breast cancer‐related lymphedema: clinical implications. J Plast Reconstr Aesthet Surg. 2020;73(6):1018‐1024. doi:10.1016/j.bjps.2019.11.053
Koelmeyer LA, Thompson BM, Mackie H, et al. Personalizing conservative lymphedema management using indocyanine green‐guided manual lymphatic drainage. Lymphat Res Biol. 2021;19(1):56‐65. doi:10.1089/lrb.2020.0090
Suami H, Koelmeyer L, Mackie H, Boyages J. Patterns of lymphatic drainage after axillary node dissection impact arm lymphoedema severity: a review of animal and clinical imaging studies. Surg Oncol. 2018;27(4):743‐750. doi:10.1016/j.suronc.2018.10.006
Vignes S, Arrault M, Yannoutsos A, Blanchard M. Primary upper‐limb lymphoedema. Br J Dermatol. 2013;168(2):272‐276. doi:10.1111/bjd.12024
Ma X, Wen S, Liu B, et al. Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer. J Oncol. 2019;2019:8637895. doi:10.1155/2019/8637895

Auteurs

James E Fanning (JE)

Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Dhruv Singhal (D)

Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Hayley M Reynolds (HM)

Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.

Tharanga D Jayathungage Don (TDJ)

Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.

Kevin J Donohoe (KJ)

Department of Nuclear Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Hiroo Suami (H)

Australian Lymphoedema Education Research and Treatment Program (ALERT), Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.

David K V Chung (DKV)

Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Alfred Nuclear Medicine and Ultrasound, S206 RPAH Medical Centre, Newtown, New South Wales, Australia.

Classifications MeSH